US20020010412A1 - Multiple mechanical microporation of skin or mucosa - Google Patents
Multiple mechanical microporation of skin or mucosa Download PDFInfo
- Publication number
- US20020010412A1 US20020010412A1 US09/852,935 US85293501A US2002010412A1 US 20020010412 A1 US20020010412 A1 US 20020010412A1 US 85293501 A US85293501 A US 85293501A US 2002010412 A1 US2002010412 A1 US 2002010412A1
- Authority
- US
- United States
- Prior art keywords
- base
- puncturing
- mucosa
- skin
- holes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0053—Methods for producing microneedles
Definitions
- This invention relates to a device and method for puncturing a selected layer or layers of the skin or mucosa. More particularly, the invention relates a device and method for puncturing the stratum corneum or mucosa to diminish the barrier function thereof and permit a drug to be delivered to the body or an analyte in the body to be withdrawn for monitoring.
- This puncturing of the stratum corneum or mucosa is minimally is invasive, and can be combined with various other methods, such as use of chemical enhancers, pressure gradients, sonic gradients, temperature gradients, and the like for selectively enhancing the inward flux of a drug to the body or the outward flux of an analyte from the body.
- the stratum corneum is chiefly responsible for the well-known barrier properties of skin. Thus, it is this layer of the skin that presents the greatest barrier to transdermal flux of drugs or other molecules into the body and of analytes out of the body. Mucosal tissue also presents a barrier to flux of molecules into and out of the body.
- the stratum corneum, the outer horny layer of the skin, is a complex structure of compact keratinized cell remnants separated by lipid domains. Compared to the oral or gastric mucosa, the stratum corneum is much less permeable to molecules either external or internal to the body.
- U.S. Pat. No. 5,458,140 and U.S. Pat. No. 5,445,611 disclose using ultrasonic energy that is modulated in intensity, phase, or frequency or a combination thereof.
- U.S. Pat. No. 4,775,361 discloses a method of administering a drug by ablating the stratum corneum using pulsed laser light without significantly damaging the underlying epidermis.
- Numerous patents teach the use of chemical enhancers for improving transdermal flux of a drug through the skin. E.g., U.S. Pat. No. 4,863,970. It would be advantageous to develop additional methods of permeating the stratum corneum or mucosa to enhance the transport of drugs into the body or analytes out of the body, particularly without the need for expensive or complicated equipment.
- the device is fabricated by microlithography and is composed of a material selected from the group consisting of silicon, metal, and plastic. It is also preferred that the puncturing member be in the shape of a pyramid or wedge. The pyramid or wedge preferably have sharp edges having corner radii of less than 1 ⁇ m.
- the puncturing member is preferably configured for puncturing the skin or mucosa to a depth of about 30-50 ⁇ m, and a dimension at a base thereof is preferably about 10-50 ⁇ m.
- the puncturing members preferably occupy up to about 50% of the surface area of the lower surface of the base.
- the device preferably further comprises a mechanism for producing vibrations, the vibrations for facilitating efficient and non-traumatic penetration of the puncturing members into the skin or mucosa.
- a preferred vibration-producing mechanism comprises a piezo-electric transducer. It is preferred that the mechanism for producing vibrations produces vibrations in the range of about 2000 Hz to about 100 MHz.
- an external reservoir for holding a liquid drug composition to be delivered to the body is provided.
- a mechanism for limiting the rate of drug delivery is preferably included in the device, the mechanism positioned between the external reservoir and the puncturing members.
- rate-limiting mechanisms can include selective permeability membranes and valve mechanisms.
- the device is disposable.
- a method for reducing the barrier function of skin or mucosa to the delivery of substances into a body or withdrawal of analytes out of the body comprises:
- a base having a lower side and an upper side
- a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing the skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
- a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action;
- a network of channels configured in the upper side of the base to interconnect the holes
- a method of transdermal or transmucosal monitoring of a selected analyte in a body comprises:
- a base having a lower side and an upper side
- a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing said skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
- a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action;
- a network of channels configured in the upper side of the base to interconnect the holes, the network of channels including a reservoir;
- the method further comprises applying suction to increase the rate of collection of interstitial fluid.
- Ultrasonic vibrations can also be applied to the skin or mucosa to increase the rate of collection of the selected analyte.
- the ultrasonic vibrations can be modulated in frequency, intensity, phase, or a combination thereof, as disclosed in U.S. Pat. No. 5,458,140, hereby incorporated by reference.
- the ultrasonic vibrations are preferably in the range of about 2000 Hz to about 100 MHz.
- the ultrasonic vibrations can also enhance the movement of interstitial fluid by capillary action.
- the selected analyte is glucose. It is also preferred to apply an anticoagulant to inhibit obstruction of the holes or channels.
- a method of transdermally or transmucosally delivering a drug in liquid form to a body comprises:
- a base having a lower side and an upper side
- a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing the skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
- a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action;
- a network of channels configured in the upper side of the base to interconnect the holes, the network of channels including a reservoir;
- pressure is applied to increase the rate of delivery of the drug to the body.
- Applying ultrasonic vibrations to the skin or mucosa also increases the rate of delivery of the drug to the body.
- the ultrasonic vibrations can be modulated in frequency, intensity, phase, or a combination thereof, as disclosed in U.S. Pat. No. 5,445,611, hereby incorporated by reference.
- the ultrasonic vibrations are preferably in the range of about 2000 Hz to about 100 MHz.
- the drug in liquid form can further comprise an anti-irritant, antiseptic, or analgesic to reduce trauma to the body due to the application of the device.
- FIG. 1 shows a perspective view of an illustrative embodiment of the present invention.
- FIG. 2 shows a cross section of a portion of another illustrative embodiment according to the present invention.
- FIG. 3 shows a perspective view of a portion of the embodiment of FIG. 2.
- FIG. 5 shows a schematic diagram of a device for making multiple microporations in skin or mucosa and collecting interstitial fluid.
- FIG. 6 shows a schematic sectional diagram of a device for making multiple microporations in skin or mucosa and delivering a drug.
- One illustrative method would be to utilize the existing base of manufacturing capabilities developed in the semiconductor and micro-mechanical industries to dry-etch an entire 4 inch silicon wafer with a network of these devices. This master could then be used as the basis for an electroplated mold from which thousands of copies could be produced. For a typical useable surface area/per device application of 4 mm ⁇ 4 mm, one 4-inch wafer would yield more than 500 of the devices.
- a device according to the present invention is made, for example, by first preparing a master by a dry etch process on a silicon wafer, as is well known in the art. Photolithographical processes for etching micrometer-scale structures into silicon waters and the like are described in A. T. Wooley & R. A. Mathies, Ultra-high-speed DNA fragment separations using microfabricated capillary array electrophoresis chips, 91 Biophysics 11348-52 (1994); C. S. Effenhauser et al., High-speed separation of antisense oligonucleotides on a micromachined capillary electrophoresis device, 66 Anal. Chem. 2949 (1994); C.
- ultrasound has been shown to enhance the smooth cutting ability of scalpels and other surgical devices and can be expected to facilitate the easy, painless penetration of the puncturing elements into the stratum corneum with very little pressure.
- the edges of the pyramidally shaped puncturing elements shown in FIG. 1 can easily be fabricated such that the corner radius is less than 10 nanometers, a sharpness similar to a surgical scalpel.
- ultrasound has also been shown to greatly enhance capillary action, thus the amount of fluid that could be collected in a device containing a capillary collection system could be expected to be significantly greater than that provided by mere passive means.
- FIG. 1 shows a perspective view of an illustrative device according to the present invention.
- the device 10 comprises a base 14 with a plurality of puncturing members 18 extending therefrom.
- the base is substantially planar.
- Each puncturing member comprises a sharp point 22 or edge for puncturing the stratum corneum or mucosa. Since the stratum corneum can be up to about 30 ⁇ m thick, it is preferred that the puncturing element have a height of about 40-50 ⁇ m to ensure that the stratum corneum will be fully breached without significantly damaging the underlying tissue.
- a pyramid or wedge shape is a preferred shape for the puncturing member because of the ease with which such a shape can be formed by microfabrication techniques such as microlithography.
- the base of the pyramid would preferably have a square base about 30-40 ⁇ m on a side.
- the base have a plurality of holes 26 extending therethrough from the lower side 30 , on which the puncturing element are disposed, to the upper side 34 .
- each puncturing element is adjacent to and paired with at least one hole for collecting the interstitial fluid that seeps out of the puncture in the stratum corneum.
- These holes should be dimensioned to permit the interstitial fluid to move by capillary action from the lower side of the device to the upper side, where the interstitial fluid can be collected.
- FIGS. 2,3, and 4 shows how the V-grooves 70 interconnect the V-channels for collecting the interstitial fluid. All of the puncturing members, channels, and grooves shown in FIGS. 2,3, and 4 are designed to be wedge-shaped, compatible with being produced in the crystalline structure of a silicon substrate with a lithographic ‘dry-etch’ type of process.
- FIG. 5 shows an illustrative device 80 for collecting interstitial fluid according to the present invention.
- the device 80 comprises a base 84 having a plurality of puncturing members 88 extending therefrom.
- V-shaped channels and grooves are configured into the upper side 92 of the base for collecting the interstitial fluid.
- a cover plate 96 fits over the base to cover the network of channels and grooves and to inhibit evaporation of the interstitial fluid.
- the network of channels and grooves leads the interstitial fluid to a central area, where there is disposed a capillary tube 100 for receiving the interstitial fluid.
- Atop the cover plate is disposed an ultrasonic transducer 104 and a backing 108 for the tranducer.
- the device is pressed against a selected area of skin or mucosa, and the ultrasonic transducer is activated to aid in both the puncturing of the tissue and in enhancing the seepage of the interstitial fluid.
- the interstitial fluid is collected by the network of openings in the base, and is conducted by the network of channels and grooves to the capillary, which takes up the fluid by capillary action.
- the fluid is then analyzed according to methods known in the art.
- An illustrative analyte is glucose, which can be quantified with various test strips that are available commercially.
- FIG. 6 shows an illustrative drug delivery device 120 comprising a base 124 having a plurality of puncturing members 128 extending therefrom.
- a network of grooves and channels (see FIGS. 2 - 4 ) is embedded in the base for distributing a drug composition 132 from a reservoir 136 .
- the reservoir is bounded by a housing 138 , the base, and a backing plate 144 including an O-ring 148 .
- the drug composition flows through the channels, grooves, and openings in the base to the surface of the skin or mucosa for entry into the body through the punctures or perforations.
- An ultrasound transducer 140 lies over the drug composition for aiding in delivery thereof. Above the transducer is the backing plate 144 including the O-ring for sealing the drug in the reservoir.
- a spring 152 can advantageously bias the backing plate against the transducer, which causes the transducer to be kept in fluid contact with the drug.
- the ultrasonic system is utilized not only to enhance the slicing action of the edges of the puncturing elements as the penetrate into the stratum corneum or mucosa, but is then utilized to enhance the fluid flux of the therapeutic containing solution through the micro-pores and into the underlying tissues.
- large quantities of large molecular weight drugs could be delivered transdermally with a programmable control of the flux rate via variable activation of the ultrasonic pumping system.
- the sonic energy can be utilized to create controlled resonant vibrations in specifically shaped micro-structures such that a micro-pump is created to facilitate driving the collected fluid from one point to another within the entire structure.
- chemical enhancers, air pressure, and other methods known in the art can be used to enhance the passage of the drug through the micropores in the skin or mucosa into the body.
Abstract
Description
- This application claims the benefit of U.S. Provisional Application No. 60/021,212, filed Jul. 3, 1996.
- This invention relates to a device and method for puncturing a selected layer or layers of the skin or mucosa. More particularly, the invention relates a device and method for puncturing the stratum corneum or mucosa to diminish the barrier function thereof and permit a drug to be delivered to the body or an analyte in the body to be withdrawn for monitoring. This puncturing of the stratum corneum or mucosa is minimally is invasive, and can be combined with various other methods, such as use of chemical enhancers, pressure gradients, sonic gradients, temperature gradients, and the like for selectively enhancing the inward flux of a drug to the body or the outward flux of an analyte from the body.
- The stratum corneum is chiefly responsible for the well-known barrier properties of skin. Thus, it is this layer of the skin that presents the greatest barrier to transdermal flux of drugs or other molecules into the body and of analytes out of the body. Mucosal tissue also presents a barrier to flux of molecules into and out of the body. The stratum corneum, the outer horny layer of the skin, is a complex structure of compact keratinized cell remnants separated by lipid domains. Compared to the oral or gastric mucosa, the stratum corneum is much less permeable to molecules either external or internal to the body. The stratum corneum is formed from keratinocytes, which comprise the majority of the epidermal cells, that lose their nuclei and become corneocytes. These dead cells comprise the stratum corneum, which has a thickness of about 10-30 μm and, as noted above, is a very resistant waterproof membrane that protects the body from invasion by exterior substances and the outward migration of fluids and dissolved molecules. The stratum corneum is continuously renewed by shedding of corneum cells during desquamination and the formation of new corneum cells by the keratinization process.
- Various methods of enhancing the permeability of the stratum corneum and mucosa have been described. For example, U.S. Pat. No. 5,458,140 and U.S. Pat. No. 5,445,611 disclose using ultrasonic energy that is modulated in intensity, phase, or frequency or a combination thereof. U.S. Pat. No. 4,775,361 discloses a method of administering a drug by ablating the stratum corneum using pulsed laser light without significantly damaging the underlying epidermis. Numerous patents teach the use of chemical enhancers for improving transdermal flux of a drug through the skin. E.g., U.S. Pat. No. 4,863,970. It would be advantageous to develop additional methods of permeating the stratum corneum or mucosa to enhance the transport of drugs into the body or analytes out of the body, particularly without the need for expensive or complicated equipment.
- In view of the foregoing, it will be appreciated that providing a device and method of use thereof for introducing multiple micropores or perforations in the stratum corneum or mucosa for enhancing transport of molecules therethrough would be a significant advancement in the art.
- It is an object of the present invention to provide a simple, inexpensive device for puncturing the stratum corneum or mucosa without significantly damaging the underlying tissues to facilitate transport of molecules therethrough.
- It is also an object of the invention to provide a method of enhancing the passage of molecules through the stratum corneum or mucosa.
- It is another object of the invention to provide a method for transdermally or transmucosally delivering a drug.
- It is still another object of the invention to provide a method for transdermally or transmucosally monitoring an analyte.
- These and other objects can be achieved by providing a device for reducing the barrier properties of skin or mucosa to the delivery of a substance into the body or the withdrawal of an analyte from the body comprising:
- (a) a base having a lower side and an upper side;
- (b) a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing the skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
- (c) a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action; and
- (d) a network of channels configured in the upper side of the base to interconnect the holes.
- Preferably, the device is fabricated by microlithography and is composed of a material selected from the group consisting of silicon, metal, and plastic. It is also preferred that the puncturing member be in the shape of a pyramid or wedge. The pyramid or wedge preferably have sharp edges having corner radii of less than 1 μm. The puncturing member is preferably configured for puncturing the skin or mucosa to a depth of about 30-50 μm, and a dimension at a base thereof is preferably about 10-50 μm. The puncturing members preferably occupy up to about 50% of the surface area of the lower surface of the base.
- The device preferably further comprises a mechanism for producing vibrations, the vibrations for facilitating efficient and non-traumatic penetration of the puncturing members into the skin or mucosa. A preferred vibration-producing mechanism comprises a piezo-electric transducer. It is preferred that the mechanism for producing vibrations produces vibrations in the range of about 2000 Hz to about 100 MHz.
- In another illustrative embodiment of the device, an external reservoir for holding a liquid drug composition to be delivered to the body is provided. Still further, a mechanism for limiting the rate of drug delivery is preferably included in the device, the mechanism positioned between the external reservoir and the puncturing members. Such rate-limiting mechanisms can include selective permeability membranes and valve mechanisms. In another preferred embodiment, the device is disposable.
- A method for reducing the barrier function of skin or mucosa to the delivery of substances into a body or withdrawal of analytes out of the body, comprises:
- (a) providing a device comprising:
- a base having a lower side and an upper side;
- a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing the skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
- a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action; and
- a network of channels configured in the upper side of the base to interconnect the holes;
- (b) contacting the device with the skin or mucosa such that the plurality of puncturing members puncture the skin or mucosa to a depth sufficient to reduce the barrier properties thereof.
- A method of transdermal or transmucosal monitoring of a selected analyte in a body comprises:
- (a) providing a device comprising:
- a base having a lower side and an upper side;
- a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing said skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
- a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action; and
- a network of channels configured in the upper side of the base to interconnect the holes, the network of channels including a reservoir;
- (b) contacting the device with the skin or mucosa such that the plurality of puncturing members puncture the skin or mucosa to a depth sufficient to reduce the barrier properties thereof resulting in seepage of interstitial fluid to the surface of the skin or mucosa such that interstitial fluid moves by capillary action through the holes, through the channels, to the reservoir;
- (c) collecting the interstitial fluid from the reservoir; and
- (d) analyzing the interstitial fluid with respect to the selected analyte.
- In a preferred embodiment, the method further comprises applying suction to increase the rate of collection of interstitial fluid. Ultrasonic vibrations can also be applied to the skin or mucosa to increase the rate of collection of the selected analyte. The ultrasonic vibrations can be modulated in frequency, intensity, phase, or a combination thereof, as disclosed in U.S. Pat. No. 5,458,140, hereby incorporated by reference. The ultrasonic vibrations are preferably in the range of about 2000 Hz to about 100 MHz. The ultrasonic vibrations can also enhance the movement of interstitial fluid by capillary action. In a preferred embodiment of the invention, the selected analyte is glucose. It is also preferred to apply an anticoagulant to inhibit obstruction of the holes or channels.
- A method of transdermally or transmucosally delivering a drug in liquid form to a body comprises:
- (a) providing a device comprising:
- a base having a lower side and an upper side;
- a plurality of puncturing members extending from the lower side of the base, the puncturing members configured for puncturing the skin or mucosa to a depth sufficient to reduce the barrier properties thereof without significantly damaging underlying tissues;
- a plurality of holes extending from the lower side of the base to the upper side of the base, the holes configured for permitting a liquid to move therethrough by capillary action; and
- a network of channels configured in the upper side of the base to interconnect the holes, the network of channels including a reservoir;
- (b) contacting the device with the skin or mucosa such that the plurality of puncturing members puncture the skin or mucosa to a depth sufficient to reduce the barrier properties thereof;
- (c) supplying the drug to the reservoir such that said drug moves from the reservoir, through the channels and holes to the site of the punctures of the skin or mucosa and thus into the body.
- In a preferred embodiment, pressure is applied to increase the rate of delivery of the drug to the body. Applying ultrasonic vibrations to the skin or mucosa also increases the rate of delivery of the drug to the body. The ultrasonic vibrations can be modulated in frequency, intensity, phase, or a combination thereof, as disclosed in U.S. Pat. No. 5,445,611, hereby incorporated by reference. The ultrasonic vibrations are preferably in the range of about 2000 Hz to about 100 MHz. The drug in liquid form can further comprise an anti-irritant, antiseptic, or analgesic to reduce trauma to the body due to the application of the device.
- FIG. 1 shows a perspective view of an illustrative embodiment of the present invention.
- FIG. 2 shows a cross section of a portion of another illustrative embodiment according to the present invention.
- FIG. 3 shows a perspective view of a portion of the embodiment of FIG. 2.
- FIG. 4 shows a top view of a portion of the embodiment of FIG. 2.
- FIG. 5 shows a schematic diagram of a device for making multiple microporations in skin or mucosa and collecting interstitial fluid.
- FIG. 6 shows a schematic sectional diagram of a device for making multiple microporations in skin or mucosa and delivering a drug.
- Before the present device and method for enhancing permeability of skin or mucosa for drug delivery or analyte monitoring are disclosed and described, it is to be understood that this invention is not limited to the particular configurations, process steps, and materials disclosed herein as such configurations, process steps, and materials may vary somewhat. It is also to be understood that the terminology employed herein is used for the purpose of describing particular embodiments only and is not intended to be limiting since the scope of the present invention will be limited only by the appended claims and equivalents thereof.
- It must be noted that, as used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to a device containing “a puncturing member” includes a device containing two or more of such members, reference to “a channel” includes reference to one or more of such channels, and reference to “an ultrasound transducer” includes reference to two or more ultrasound transducers.
- It has been observed that forming a hole or micropore, 30 μm across, in the stratum corneum yields a quick source of about 0.2 microliters of interstitial fluid seeping through the hole from the underlying tissue without any additional pumping. Merely increasing the number of holes introduced through the stratum corneum would increases the amount of passively available fluid in a linear fashion. That is, creating 100 holes should produce about 20 microliters of interstitial fluid. From a practical perspective, using known approaches to create 100 holes in a controlled pattern would be challenging and time-consuming. However, using the mechanical puncturing capabilities of a mechanical microporation or “bed-of-nails” device would allow an almost unlimited number of micropores to be quickly created in any selected pattern. Similarly, using conventional lancet and needle technologies would make the needed depth control of the puncture very tricky and, if the device were to create hundreds of these holes, the mechanical challenge of building the device using conventional metal needle technologies would be formidable. However, by fabricating puncturing elements en masse such that they protrude from a substantially planar surface, with sufficient spacing between each to allow the stratum corneum to come in contact with this intervening planar surface, the absolute length of the puncturing elements themselves would act as an accurate limit for the depth of the micropore. Also, using a microlithography approach to fabricate these structures will allow an entire surface comprised of puncturing elements and the interconnecting fluid management system to be built very cost effectively.
- One illustrative method would be to utilize the existing base of manufacturing capabilities developed in the semiconductor and micro-mechanical industries to dry-etch an entire 4 inch silicon wafer with a network of these devices. This master could then be used as the basis for an electroplated mold from which thousands of copies could be produced. For a typical useable surface area/per device application of 4 mm×4 mm, one 4-inch wafer would yield more than 500 of the devices.
- A device according to the present invention is made, for example, by first preparing a master by a dry etch process on a silicon wafer, as is well known in the art. Photolithographical processes for etching micrometer-scale structures into silicon waters and the like are described in A. T. Wooley & R. A. Mathies, Ultra-high-speed DNA fragment separations using microfabricated capillary array electrophoresis chips, 91 Biophysics 11348-52 (1994); C. S. Effenhauser et al., High-speed separation of antisense oligonucleotides on a micromachined capillary electrophoresis device, 66 Anal. Chem. 2949 (1994); C. Effenhauser et al., 65 Anal. Chem. 2637 (1993); Z. H. Fan & D. J. Harrison, Micromachining of capillary electrophoresis injectors and separators on glass chips and evaluation of flow at capillary intersections, 66 Anal. Chem. 177-84 (1994); W. H. Ko et al., in Sensors: A Comprehensive Survey, T. Grandke, W. H. Ko, eds., VCH Press: Weinheim, Germany, Vol. 1, pp. 107-68 (1989); K. E. Petersen, 70 Proc. IEEE 420-57 (1982), which are hereby incorporated by reference. The master silicon wafer is then used to make an electroplated mold, and then the mold is used to make copies of the device, all by processes well known in the art.
- Also, by coupling the entire device to an ultrasonic transducer, several known advantages can be realized simultaneously. For example, ultrasound has been shown to enhance the smooth cutting ability of scalpels and other surgical devices and can be expected to facilitate the easy, painless penetration of the puncturing elements into the stratum corneum with very little pressure. The edges of the pyramidally shaped puncturing elements shown in FIG. 1 can easily be fabricated such that the corner radius is less than 10 nanometers, a sharpness similar to a surgical scalpel. Second, ultrasound has also been shown to greatly enhance capillary action, thus the amount of fluid that could be collected in a device containing a capillary collection system could be expected to be significantly greater than that provided by mere passive means. Third, by using the entire body of the puncturing elements to provide a conduit for the ultrasonic energy, a simple method is presented wherein the sonic energy is placed within the body where it can provide a positive pressure, and streaming action on the interstitial fluid from within the body outward towards a collection system of capillary channels coupling all fluid harvested into a central reservoir.
- FIG. 1 shows a perspective view of an illustrative device according to the present invention. The
device 10 comprises a base 14 with a plurality of puncturingmembers 18 extending therefrom. In a preferred embodiment, the base is substantially planar. Each puncturing member comprises asharp point 22 or edge for puncturing the stratum corneum or mucosa. Since the stratum corneum can be up to about 30 μm thick, it is preferred that the puncturing element have a height of about 40-50 μm to ensure that the stratum corneum will be fully breached without significantly damaging the underlying tissue. A pyramid or wedge shape is a preferred shape for the puncturing member because of the ease with which such a shape can be formed by microfabrication techniques such as microlithography. In an illustrative puncturing element having a pyramid shape, the base of the pyramid would preferably have a square base about 30-40 μm on a side. - It is also preferred that the base have a plurality of
holes 26 extending therethrough from thelower side 30, on which the puncturing element are disposed, to theupper side 34. Preferably, each puncturing element is adjacent to and paired with at least one hole for collecting the interstitial fluid that seeps out of the puncture in the stratum corneum. These holes should be dimensioned to permit the interstitial fluid to move by capillary action from the lower side of the device to the upper side, where the interstitial fluid can be collected. It is also preferred to interconnect the holes withcapillary channels 38 that are formed in the upper side of the device. Preferably, such channels intersect at areservoir 42. The interstitial fluid moves by capillarity from the micropore into the hole, through the channels, and to the reservoir, where the interstitial fluid is collected, such as with a micropipet. Additional fluid can be collected by applying suction to the microporated area of skin or mucosa. - FIGS.2-4 show another illustrative embodiment of the invention. FIG. 2 shows a cross section of a portion of the
device 50 comprising a base 54 with a puncturingmember 58 extending therefrom. The puncturing member is pyramid-shaped, as in FIG. 1. Theupper side 62 of the base is configured with a V-shapedchannel 66 positioned such that the channel is directly over the puncturing member and cuts into the volume circumscribed by the puncturing member. FIG. 3 shows a perspective view of the device having the V-shapedchannels 66 and interconnecting shallower V-grooves 70. Thechannels 66 cut through the lower side 74 of the base, and thus form openings through which the interstitial fluid can be taken up by capillary action. FIG. 4 shows how the V-grooves 70 interconnect the V-channels for collecting the interstitial fluid. All of the puncturing members, channels, and grooves shown in FIGS. 2,3, and 4 are designed to be wedge-shaped, compatible with being produced in the crystalline structure of a silicon substrate with a lithographic ‘dry-etch’ type of process. - FIG. 5 shows an
illustrative device 80 for collecting interstitial fluid according to the present invention. Thedevice 80 comprises a base 84 having a plurality of puncturingmembers 88 extending therefrom. V-shaped channels and grooves are configured into theupper side 92 of the base for collecting the interstitial fluid. Acover plate 96 fits over the base to cover the network of channels and grooves and to inhibit evaporation of the interstitial fluid. The network of channels and grooves leads the interstitial fluid to a central area, where there is disposed acapillary tube 100 for receiving the interstitial fluid. Atop the cover plate is disposed anultrasonic transducer 104 and abacking 108 for the tranducer. - The device is pressed against a selected area of skin or mucosa, and the ultrasonic transducer is activated to aid in both the puncturing of the tissue and in enhancing the seepage of the interstitial fluid. The interstitial fluid is collected by the network of openings in the base, and is conducted by the network of channels and grooves to the capillary, which takes up the fluid by capillary action. The fluid is then analyzed according to methods known in the art. An illustrative analyte is glucose, which can be quantified with various test strips that are available commercially.
- FIG. 6 shows an illustrative
drug delivery device 120 comprising a base 124 having a plurality of puncturingmembers 128 extending therefrom. A network of grooves and channels (see FIGS. 2-4) is embedded in the base for distributing adrug composition 132 from areservoir 136. The reservoir is bounded by ahousing 138, the base, and abacking plate 144 including an O-ring 148. The drug composition flows through the channels, grooves, and openings in the base to the surface of the skin or mucosa for entry into the body through the punctures or perforations. Anultrasound transducer 140 lies over the drug composition for aiding in delivery thereof. Above the transducer is thebacking plate 144 including the O-ring for sealing the drug in the reservoir. Aspring 152 can advantageously bias the backing plate against the transducer, which causes the transducer to be kept in fluid contact with the drug. - The ultrasonic system is utilized not only to enhance the slicing action of the edges of the puncturing elements as the penetrate into the stratum corneum or mucosa, but is then utilized to enhance the fluid flux of the therapeutic containing solution through the micro-pores and into the underlying tissues. In this case, large quantities of large molecular weight drugs could be delivered transdermally with a programmable control of the flux rate via variable activation of the ultrasonic pumping system. In addition, the sonic energy can be utilized to create controlled resonant vibrations in specifically shaped micro-structures such that a micro-pump is created to facilitate driving the collected fluid from one point to another within the entire structure. Moreover, chemical enhancers, air pressure, and other methods known in the art can be used to enhance the passage of the drug through the micropores in the skin or mucosa into the body.
Claims (48)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/852,935 US20020010412A1 (en) | 1996-07-03 | 2001-05-10 | Multiple mechanical microporation of skin or mucosa |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2121296P | 1996-07-03 | 1996-07-03 | |
US09/202,207 US6183434B1 (en) | 1996-07-03 | 1997-07-03 | Multiple mechanical microporation of skin or mucosa |
US61416400A | 2000-07-11 | 2000-07-11 | |
US09/852,935 US20020010412A1 (en) | 1996-07-03 | 2001-05-10 | Multiple mechanical microporation of skin or mucosa |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US61416400A Continuation | 1996-07-03 | 2000-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020010412A1 true US20020010412A1 (en) | 2002-01-24 |
Family
ID=21802981
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/202,207 Expired - Lifetime US6183434B1 (en) | 1996-07-03 | 1997-07-03 | Multiple mechanical microporation of skin or mucosa |
US09/852,935 Abandoned US20020010412A1 (en) | 1996-07-03 | 2001-05-10 | Multiple mechanical microporation of skin or mucosa |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/202,207 Expired - Lifetime US6183434B1 (en) | 1996-07-03 | 1997-07-03 | Multiple mechanical microporation of skin or mucosa |
Country Status (10)
Country | Link |
---|---|
US (2) | US6183434B1 (en) |
EP (1) | EP0921840B1 (en) |
JP (1) | JP3942640B2 (en) |
AT (1) | ATE241405T1 (en) |
AU (1) | AU3880697A (en) |
CA (1) | CA2259437C (en) |
DE (1) | DE69722414T2 (en) |
DK (1) | DK0921840T3 (en) |
ES (1) | ES2200187T3 (en) |
WO (1) | WO1998000193A1 (en) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040064087A1 (en) * | 2002-08-29 | 2004-04-01 | Lastovich Alexander G. | Microabrader with controlled abrasion features |
US20050119605A1 (en) * | 2002-04-19 | 2005-06-02 | Transpharma Medical Ltd. | Handheld transdermal drug delivery and analyte extraction |
US20080234626A1 (en) * | 2006-04-26 | 2008-09-25 | Chelak Todd M | Multi-stage microporation device |
US20080274166A1 (en) * | 2005-06-10 | 2008-11-06 | Transpharma Medical Ltd. | Patch for Transdermal Drug Delivery |
US20090053673A1 (en) * | 2007-08-23 | 2009-02-26 | Zimmer, Inc. | Method for localized treatment of periodontal tissue |
US20090118672A1 (en) * | 2002-10-07 | 2009-05-07 | Gonnelli Robert R | Microneedle array patch |
US20090187167A1 (en) * | 2007-12-17 | 2009-07-23 | New World Pharmaceuticals, Llc | Integrated intra-dermal delivery, diagnostic and communication system |
US20100229636A1 (en) * | 2007-10-17 | 2010-09-16 | Galit Levin | Dissolution rate verification |
US20100286588A1 (en) * | 2007-10-09 | 2010-11-11 | Transpharma Ltd. | Magnetic patch coupling |
US20100293807A1 (en) * | 2007-10-29 | 2010-11-25 | Transpharma Medical, Ltd. | Vertical patch drying |
EP2280645A2 (en) * | 2008-05-02 | 2011-02-09 | Aspect Medical Systems, Inc. | Skin preparation device and biopotential sensor |
US20110172645A1 (en) * | 2010-01-08 | 2011-07-14 | Ratio, Inc. | Wearable drug delivery device including integrated pumping and activation elements |
US20110172486A1 (en) * | 2008-06-27 | 2011-07-14 | Quentin Andrew Pankhurst | Magnetic microbubbles, methods of preparing them and their uses |
US20110172637A1 (en) * | 2010-01-08 | 2011-07-14 | Ratio, Inc. | Drug delivery device including tissue support structure |
US20110172639A1 (en) * | 2010-01-08 | 2011-07-14 | Ratio, Inc. | Device and method for delivery of microneedle to desired depth within the skin |
US20110172609A1 (en) * | 2010-01-08 | 2011-07-14 | Ratio, Inc. | Microneedle component assembly for drug delivery device |
WO2011109406A1 (en) * | 2010-03-01 | 2011-09-09 | Inovio Pharmaceuticals, Inc. | A tolerable and minimally invasive skin electroporation device |
US8668675B2 (en) | 2010-11-03 | 2014-03-11 | Flugen, Inc. | Wearable drug delivery device having spring drive and sliding actuation mechanism |
CN103687644A (en) * | 2011-06-28 | 2014-03-26 | 艾诺奥医药品有限公司 | A miniminally invasive dermal electroporation device |
CN104508675A (en) * | 2012-05-30 | 2015-04-08 | 斯科特·麦克纳尔蒂 | System, method and apparatus for electromagnetic detection and analysis of biometric information |
US9011419B2 (en) | 2007-12-05 | 2015-04-21 | Syneron Medical Ltd | Disposable electromagnetic energy applicator |
US9238102B2 (en) | 2009-09-10 | 2016-01-19 | Medipacs, Inc. | Low profile actuator and improved method of caregiver controlled administration of therapeutics |
US9500186B2 (en) | 2010-02-01 | 2016-11-22 | Medipacs, Inc. | High surface area polymer actuator with gas mitigating components |
US9504826B2 (en) | 2009-02-18 | 2016-11-29 | Syneron Medical Ltd | Skin treatment apparatus for personal use and method for using same |
US20170232246A1 (en) * | 2014-11-07 | 2017-08-17 | Toppan Printing Co., Ltd. | Needle assembly for transdermal administration and method of producing the same |
WO2018080923A1 (en) * | 2016-10-28 | 2018-05-03 | Georgetown University | Non-invasive passive interstitial fluid collector |
US9995295B2 (en) | 2007-12-03 | 2018-06-12 | Medipacs, Inc. | Fluid metering device |
US10000605B2 (en) | 2012-03-14 | 2018-06-19 | Medipacs, Inc. | Smart polymer materials with excess reactive molecules |
US10208158B2 (en) | 2006-07-10 | 2019-02-19 | Medipacs, Inc. | Super elastic epoxy hydrogel |
US11247206B2 (en) | 2017-01-31 | 2022-02-15 | Georgetown University | Harvesting cell-free non-coding RNAS (CFNCRS) from interstitial fluid for sensitive biomarkers |
Families Citing this family (242)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060240381A1 (en) | 1995-08-31 | 2006-10-26 | Biolase Technology, Inc. | Fluid conditioning system |
US20090143775A1 (en) * | 1995-08-31 | 2009-06-04 | Rizoiu Ioana M | Medical laser having controlled-temperature and sterilized fluid output |
US20020010406A1 (en) | 1996-05-17 | 2002-01-24 | Douglas Joel S. | Methods and apparatus for expressing body fluid from an incision |
US7235056B2 (en) * | 1996-05-17 | 2007-06-26 | Amira Medical | Body fluid sampling device and methods of use |
US7828749B2 (en) | 1996-05-17 | 2010-11-09 | Roche Diagnostics Operations, Inc. | Blood and interstitial fluid sampling device |
EP1579814A3 (en) | 1996-05-17 | 2006-06-14 | Roche Diagnostics Operations, Inc. | Methods and apparatus for sampling and analyzing body fluid |
US6230051B1 (en) | 1996-06-18 | 2001-05-08 | Alza Corporation | Device for enhancing transdermal agent delivery or sampling |
DE69718495T2 (en) * | 1996-09-17 | 2003-11-20 | Deka Products Lp | SYSTEM FOR DISPOSAL OF MEDICINE BY TRANSPORT |
US6797276B1 (en) | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
US5980898A (en) * | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
US20060002959A1 (en) * | 1996-11-14 | 2006-01-05 | Government Of The United States | Skin-sctive adjuvants for transcutaneous immuization |
US20060149343A1 (en) * | 1996-12-02 | 2006-07-06 | Palomar Medical Technologies, Inc. | Cooling system for a photocosmetic device |
US6517532B1 (en) * | 1997-05-15 | 2003-02-11 | Palomar Medical Technologies, Inc. | Light energy delivery head |
US8182473B2 (en) * | 1999-01-08 | 2012-05-22 | Palomar Medical Technologies | Cooling system for a photocosmetic device |
JP2001512329A (en) * | 1996-12-31 | 2001-08-21 | アルテア テクノロジーズ,インコーポレイテッド | Tissue microperforation for bioactive drug delivery |
US6527716B1 (en) | 1997-12-30 | 2003-03-04 | Altea Technologies, Inc. | Microporation of tissue for delivery of bioactive agents |
JP4056091B2 (en) * | 1997-05-15 | 2008-03-05 | パロマー・メディカル・テクノロジーズ・インコーポレーテッド | Dermatological treatment method and apparatus |
US20040258703A1 (en) * | 1997-11-14 | 2004-12-23 | The Government Of The Us, As Represented By The Secretary Of The Army | Skin-active adjuvants for transcutaneous immunization |
US6706000B2 (en) * | 1997-11-21 | 2004-03-16 | Amira Medical | Methods and apparatus for expressing body fluid from an incision |
DE19800416C2 (en) * | 1998-01-08 | 2002-09-19 | Storz Karl Gmbh & Co Kg | Device for the treatment of body tissue, in particular soft tissue close to the surface, by means of ultrasound |
US6173202B1 (en) | 1998-03-06 | 2001-01-09 | Spectrx, Inc. | Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
ATE375752T1 (en) * | 1998-03-06 | 2007-11-15 | Spectrx Inc | INTEGRATED TISSUE PORATION, FLUID COLLECTION AND ANALYSIS DEVICE |
WO1999046005A1 (en) | 1998-03-12 | 1999-09-16 | Palomar Medical Technologies, Inc. | System for electromagnetic radiation of the skin |
EP1086214B1 (en) * | 1998-06-10 | 2009-11-25 | Georgia Tech Research Corporation | Microneedle devices and methods of their manufacture |
US6503231B1 (en) | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
US7344499B1 (en) | 1998-06-10 | 2008-03-18 | Georgia Tech Research Corporation | Microneedle device for extraction and sensing of bodily fluids |
EP1090301B1 (en) | 1998-06-24 | 2002-07-31 | Transderm Technologies LLC | Non-invasive transdermal detection of analytes |
EP1199751A3 (en) * | 1998-06-30 | 2005-12-07 | Micronas GmbH | Chip arrangement |
US6352506B1 (en) | 1998-07-14 | 2002-03-05 | Altea Technologies | Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |
US7384396B2 (en) | 1998-07-21 | 2008-06-10 | Spectrx Inc. | System and method for continuous analyte monitoring |
US7037277B1 (en) | 1998-07-21 | 2006-05-02 | Spectrx, Inc. | System and method for fluid management in a continuous fluid collection and sensor device |
WO2000015102A1 (en) | 1998-09-10 | 2000-03-23 | Spectrx, Inc. | Attribute compensation for analyte detection and/or continuous monitoring |
US6597946B2 (en) * | 1998-11-09 | 2003-07-22 | Transpharma Ltd. | Electronic card for transdermal drug delivery and analyte extraction |
US6611706B2 (en) | 1998-11-09 | 2003-08-26 | Transpharma Ltd. | Monopolar and bipolar current application for transdermal drug delivery and analyte extraction |
US6708060B1 (en) | 1998-11-09 | 2004-03-16 | Transpharma Ltd. | Handheld apparatus and method for transdermal drug delivery and analyte extraction |
US6148232A (en) | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
EP1165132B1 (en) * | 1999-04-08 | 2011-10-19 | Intercell USA, Inc. | Dry formulation for transcutaneous immunization |
US6611707B1 (en) | 1999-06-04 | 2003-08-26 | Georgia Tech Research Corporation | Microneedle drug delivery device |
CA2376128C (en) * | 1999-06-04 | 2009-01-06 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
US6743211B1 (en) | 1999-11-23 | 2004-06-01 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
CA2376368C (en) * | 1999-06-08 | 2009-08-11 | Altea Technologies, Inc. | Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor |
US6256533B1 (en) | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
US6312612B1 (en) | 1999-06-09 | 2001-11-06 | The Procter & Gamble Company | Apparatus and method for manufacturing an intracutaneous microneedle array |
US6379324B1 (en) | 1999-06-09 | 2002-04-30 | The Procter & Gamble Company | Intracutaneous microneedle array apparatus |
US6925317B1 (en) | 1999-06-11 | 2005-08-02 | Spectrx, Inc. | Integrated alignment devices, system, and methods for efficient fluid extraction, substance delivery and other applications |
CA2376952A1 (en) | 1999-06-11 | 2000-12-21 | Mark A. Samuels | Alignment devices and methods for fluid extraction from tissue and substance delivery |
US6607495B1 (en) * | 1999-06-18 | 2003-08-19 | University Of Virginia Patent Foundation | Apparatus for fluid transport and related method thereof |
US20030078499A1 (en) * | 1999-08-12 | 2003-04-24 | Eppstein Jonathan A. | Microporation of tissue for delivery of bioactive agents |
US6623457B1 (en) | 1999-09-22 | 2003-09-23 | Becton, Dickinson And Company | Method and apparatus for the transdermal administration of a substance |
US6835184B1 (en) * | 1999-09-24 | 2004-12-28 | Becton, Dickinson And Company | Method and device for abrading skin |
ATE310561T1 (en) | 1999-12-10 | 2005-12-15 | Alza Corp | APPARATUS AND METHOD FOR IMPROVING MICRONEEDLE SKIN PIERCING |
IL150604A0 (en) * | 2000-01-25 | 2003-02-12 | Palomar Medical Tech Inc | Method and apparatus for medical treatment utilizing long duration electromagnetic radiation |
AU2001245472A1 (en) * | 2000-03-09 | 2001-09-17 | Nanopass Ltd. | Systems and methods for the transport of fluids through a biological barrier andproduction techniques for such systems |
US6595947B1 (en) | 2000-05-22 | 2003-07-22 | Becton, Dickinson And Company | Topical delivery of vaccines |
US6565532B1 (en) | 2000-07-12 | 2003-05-20 | The Procter & Gamble Company | Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup |
US6540675B2 (en) * | 2000-06-27 | 2003-04-01 | Rosedale Medical, Inc. | Analyte monitor |
US6440096B1 (en) * | 2000-07-14 | 2002-08-27 | Becton, Dickinson And Co. | Microdevice and method of manufacturing a microdevice |
RU2272618C2 (en) | 2000-09-08 | 2006-03-27 | Алза Корпорейшн | Method for inhibiting reduction of transdermal drug movement by inhibiting paths closing |
EP1335764B1 (en) * | 2000-09-08 | 2007-06-06 | Insulet Corporation | Device and system for patient infusion |
JP2002085561A (en) * | 2000-09-14 | 2002-03-26 | Terumo Corp | Liquid injection needle |
WO2002030506A2 (en) * | 2000-10-12 | 2002-04-18 | Ink Jet Technology Ltd. | Transdermal method |
US7419481B2 (en) | 2000-10-13 | 2008-09-02 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
US6882884B1 (en) | 2000-10-13 | 2005-04-19 | Soundskin, L.L.C. | Process for the stimulation of production of extracellular dermal proteins in human tissue |
HUP0303576A2 (en) | 2000-10-13 | 2004-01-28 | Alza Corp | Microprotrusion member retainer for impact applicator |
CN100391404C (en) | 2000-10-13 | 2008-06-04 | 阿尔扎公司 | Microblade array impact applicator |
NZ525294A (en) | 2000-10-13 | 2005-02-25 | Alza Corp | Apparatus and method for piercing skin with microprotrusions |
US7828827B2 (en) | 2002-05-24 | 2010-11-09 | Corium International, Inc. | Method of exfoliation of skin using closely-packed microstructures |
US7131987B2 (en) | 2000-10-16 | 2006-11-07 | Corium International, Inc. | Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation |
US6821281B2 (en) | 2000-10-16 | 2004-11-23 | The Procter & Gamble Company | Microstructures for treating and conditioning skin |
CA2427381A1 (en) | 2000-10-26 | 2002-11-28 | Alza Corporation | Transdermal drug delivery devices having coated microprotrusions |
WO2002064193A2 (en) | 2000-12-14 | 2002-08-22 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
AU2002231207A1 (en) | 2000-12-21 | 2002-07-01 | Biovalve Technologies, Inc. | Microneedle array systems |
US20060004347A1 (en) * | 2000-12-28 | 2006-01-05 | Palomar Medical Technologies, Inc. | Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor |
US20080214988A1 (en) * | 2000-12-28 | 2008-09-04 | Palomar Medical Technologies, Inc. | Methods And Devices For Fractional Ablation Of Tissue |
AU2002306576A1 (en) | 2001-02-23 | 2002-09-12 | Technical Graphics Security Products, Llc | Security label having security element and method of making same |
US6888319B2 (en) * | 2001-03-01 | 2005-05-03 | Palomar Medical Technologies, Inc. | Flashlamp drive circuit |
EP1365699A2 (en) * | 2001-03-02 | 2003-12-03 | Palomar Medical Technologies, Inc. | Apparatus and method for photocosmetic and photodermatological treatment |
US6663820B2 (en) | 2001-03-14 | 2003-12-16 | The Procter & Gamble Company | Method of manufacturing microneedle structures using soft lithography and photolithography |
US6855372B2 (en) | 2001-03-16 | 2005-02-15 | Alza Corporation | Method and apparatus for coating skin piercing microprojections |
EP1752189A3 (en) | 2001-04-20 | 2007-02-21 | Alza Corporation | Microprojection array having a beneficial agent containing coating |
DE60233939D1 (en) | 2001-04-20 | 2009-11-19 | Alza Corp | MICROPROJECTION ARRANGEMENT WITH A COATING CONTAINING ADVANTAGEOUS MEDIUM |
US20070042315A1 (en) * | 2005-06-24 | 2007-02-22 | Biolase Technology, Inc. | Visual feedback implements for electromagnetic energy output devices |
US6591124B2 (en) | 2001-05-11 | 2003-07-08 | The Procter & Gamble Company | Portable interstitial fluid monitoring system |
US6840910B2 (en) | 2001-08-01 | 2005-01-11 | Johnson & Johnson Consumer Companies, Inc. | Method of distributing skin care products |
US6855117B2 (en) | 2001-08-01 | 2005-02-15 | Johnson & Johnson Consumer Companies, Inc. | Method of treating the skin of a subject |
US6790179B2 (en) | 2001-08-01 | 2004-09-14 | Johnson & Johnson Consumer Companies, Inc. | Method of examining and diagnosing skin health |
US20020188223A1 (en) | 2001-06-08 | 2002-12-12 | Edward Perez | Devices and methods for the expression of bodily fluids from an incision |
AU2002312380A1 (en) * | 2001-06-08 | 2002-12-23 | Becton, Dickinson And Company | Device for manipulating a needle or abrader array |
US6793632B2 (en) | 2001-06-12 | 2004-09-21 | Lifescan, Inc. | Percutaneous biological fluid constituent sampling and measurement devices and methods |
US6721586B2 (en) | 2001-06-12 | 2004-04-13 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
US6875613B2 (en) | 2001-06-12 | 2005-04-05 | Lifescan, Inc. | Biological fluid constituent sampling and measurement devices and methods |
US6501976B1 (en) | 2001-06-12 | 2002-12-31 | Lifescan, Inc. | Percutaneous biological fluid sampling and analyte measurement devices and methods |
US6837988B2 (en) | 2001-06-12 | 2005-01-04 | Lifescan, Inc. | Biological fluid sampling and analyte measurement devices and methods |
US20030028125A1 (en) * | 2001-08-06 | 2003-02-06 | Yuzhakov Vadim V. | Physiological sample collection devices and methods of using the same |
US6881203B2 (en) * | 2001-09-05 | 2005-04-19 | 3M Innovative Properties Company | Microneedle arrays and methods of manufacturing the same |
JP2005503210A (en) * | 2001-09-14 | 2005-02-03 | ザ プロクター アンド ギャンブル カンパニー | Microstructure for delivering compositions to the skin through the skin using a rotatable structure |
US20040087992A1 (en) * | 2002-08-09 | 2004-05-06 | Vladimir Gartstein | Microstructures for delivering a composition cutaneously to skin using rotatable structures |
WO2003024507A2 (en) | 2001-09-19 | 2003-03-27 | Biovalve Technologies, Inc. | Microneedles, microneedle arrays, and systems and methods relating to same |
WO2003024508A2 (en) | 2001-09-21 | 2003-03-27 | Biovalve Technologies, Inc. | Gas pressure actuated microneedle arrays, and systems and methods relating to same |
US7429258B2 (en) * | 2001-10-26 | 2008-09-30 | Massachusetts Institute Of Technology | Microneedle transport device |
US20040120964A1 (en) * | 2001-10-29 | 2004-06-24 | Mikszta John A. | Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
JP2005511248A (en) * | 2001-10-29 | 2005-04-28 | ベクトン・ディキンソン・アンド・カンパニー | Methods and devices for delivering substances |
US20040147984A1 (en) * | 2001-11-29 | 2004-07-29 | Palomar Medical Technologies, Inc. | Methods and apparatus for delivering low power optical treatments |
US6952604B2 (en) * | 2001-12-21 | 2005-10-04 | Becton, Dickinson And Company | Minimally-invasive system and method for monitoring analyte levels |
WO2003057059A1 (en) * | 2001-12-27 | 2003-07-17 | Palomar Medical Technologies, Inc. | Method and apparatus for improved vascular related treatment |
US20040073175A1 (en) * | 2002-01-07 | 2004-04-15 | Jacobson James D. | Infusion system |
US6908453B2 (en) * | 2002-01-15 | 2005-06-21 | 3M Innovative Properties Company | Microneedle devices and methods of manufacture |
MXPA04007389A (en) | 2002-02-04 | 2004-10-11 | Becton Dickinson Co | Device and method for delivering or withdrawing a substance through the skin. |
US7004928B2 (en) * | 2002-02-08 | 2006-02-28 | Rosedale Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
EP2319578B1 (en) * | 2002-03-11 | 2016-11-02 | Nitto Denko Corporation | Transdermal drug delievery patch system, method of making same and method of using same |
US9918665B2 (en) | 2002-03-11 | 2018-03-20 | Nitto Denko Corporation | Transdermal porator and patch system and method for using same |
US8116860B2 (en) | 2002-03-11 | 2012-02-14 | Altea Therapeutics Corporation | Transdermal porator and patch system and method for using same |
US7060192B2 (en) | 2002-05-09 | 2006-06-13 | Lifescan, Inc. | Methods of fabricating physiological sample collection devices |
US20070239142A1 (en) * | 2006-03-10 | 2007-10-11 | Palomar Medical Technologies, Inc. | Photocosmetic device |
BR0312430A (en) | 2002-06-19 | 2005-04-26 | Palomar Medical Tech Inc | Method and apparatus for treating skin and subcutaneous conditions |
BR0311901A (en) * | 2002-06-19 | 2005-04-05 | Gen Hospital Corp | Process and apparatus for photothermal deep tissue treatment |
KR101323980B1 (en) * | 2002-07-19 | 2013-10-30 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | Microneedle device, method of using microneedle device and method of delivering microneedle device |
US20070219604A1 (en) * | 2006-03-20 | 2007-09-20 | Palomar Medical Technologies, Inc. | Treatment of tissue with radiant energy |
EP2522293A2 (en) * | 2002-10-23 | 2012-11-14 | Palomar Medical Technologies, Inc. | Phototreatment device for use with coolants and topical substances |
WO2004058352A2 (en) * | 2002-12-20 | 2004-07-15 | Palomar Medical Technologies, Inc. | Apparatus for light treatment of acne and other disorders of follicles |
CA2515843A1 (en) * | 2003-02-19 | 2004-09-02 | Palomar Medical Technologies, Inc. | Method and apparatus for treating pseudofolliculitis barbae |
US7578954B2 (en) * | 2003-02-24 | 2009-08-25 | Corium International, Inc. | Method for manufacturing microstructures having multiple microelements with through-holes |
US7052652B2 (en) | 2003-03-24 | 2006-05-30 | Rosedale Medical, Inc. | Analyte concentration detection devices and methods |
US20080149524A1 (en) * | 2003-03-27 | 2008-06-26 | Rademaker William B | Food containers including dental cleaning devices and other personal care items |
ES2737835T3 (en) | 2003-04-23 | 2020-01-16 | Valeritas Inc | Hydraulically driven pump for long-term medication administration |
JP2004343275A (en) * | 2003-05-14 | 2004-12-02 | Murata Mach Ltd | Image processing system and scanner |
EP1638523B8 (en) | 2003-06-30 | 2013-12-25 | ALZA Corporation | Formulations for coated microprojections containing non-volatile counterions |
US20050059166A1 (en) * | 2003-09-11 | 2005-03-17 | Robert Markes | Sampling instrument |
US8016811B2 (en) * | 2003-10-24 | 2011-09-13 | Altea Therapeutics Corporation | Method for transdermal delivery of permeant substances |
CN1897898A (en) | 2003-10-24 | 2007-01-17 | 阿尔扎公司 | Pretreatment method and system for enhancing transdermal drug delivery |
WO2005044139A2 (en) | 2003-10-28 | 2005-05-19 | Alza Corporation | Method and apparatus for reducing the incidence of tobacco use |
AU2004287414B2 (en) | 2003-10-31 | 2010-11-25 | Alza Corporation | Self-actuating applicator for microprojection array |
CA2546723A1 (en) * | 2003-11-21 | 2005-06-09 | Alza Corporation | Ultrasound assisted transdermal vaccine delivery method and system |
MXPA06006041A (en) * | 2003-11-28 | 2007-01-31 | Acrux Dds Pty Ltd | Method and system for rapid transdermal administration. |
WO2005065565A1 (en) * | 2003-12-31 | 2005-07-21 | Palomar Medical Technologies, Inc. | Dermatological treatment with vusualization |
US20100151406A1 (en) | 2004-01-08 | 2010-06-17 | Dmitri Boutoussov | Fluid conditioning system |
KR20060134050A (en) * | 2004-01-09 | 2006-12-27 | 알자 코포레이션 | Frequency assisted transdermal agent delivery method and system |
PL1725168T3 (en) | 2004-03-06 | 2016-10-31 | Body fluid sampling device | |
US7819822B2 (en) * | 2004-03-06 | 2010-10-26 | Roche Diagnostics Operations, Inc. | Body fluid sampling device |
AU2005228145B2 (en) * | 2004-03-24 | 2011-03-03 | Corium Pharma Solutions, Inc. | Transdermal delivery device |
JP5065005B2 (en) | 2004-04-01 | 2012-10-31 | ザ ジェネラル ホスピタル コーポレイション | Method and apparatus for dermatological treatment and tissue remodeling |
JP4981660B2 (en) * | 2004-04-12 | 2012-07-25 | アラーガン、インコーポレイテッド | Multi-site injection system |
US7315758B2 (en) | 2004-06-03 | 2008-01-01 | Lynntech, Inc. | Transdermal delivery of therapeutic agent |
WO2006014425A1 (en) * | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
AU2005299759A1 (en) * | 2004-10-21 | 2006-05-04 | Bayer Healthcare Llc | Method of determining the concentration of an analyte in a body fluid and system therefor |
US20060253176A1 (en) * | 2005-02-18 | 2006-11-09 | Palomar Medical Technologies, Inc. | Dermatological treatment device with deflector optic |
BRPI0607903A2 (en) * | 2005-02-18 | 2009-10-20 | Palomar Medical Tech Inc | dermatological treatment device |
US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
BRPI0611186A2 (en) * | 2005-06-03 | 2010-08-24 | Biolase Tech Inc | Tissue treatment device and method |
US20060281187A1 (en) * | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
TWI419717B (en) * | 2005-06-17 | 2013-12-21 | Altea Therapeutics Corp | Permeant delivery system and methods for use thereof |
AU2006292526A1 (en) | 2005-09-15 | 2007-03-29 | Palomar Medical Technologies, Inc. | Skin optical characterization device |
US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
CA2623589C (en) * | 2005-09-30 | 2014-07-22 | Intuity Medical, Inc. | Catalysts for body fluid sample extraction |
US20070194717A1 (en) * | 2006-02-17 | 2007-08-23 | Palomar Medical Technologies, Inc. | Lamp for use in a tissue treatment device |
CA2646324C (en) | 2006-03-30 | 2016-06-07 | Valeritas, Llc | Multi-cartridge fluid delivery device |
WO2007117580A2 (en) * | 2006-04-06 | 2007-10-18 | Palomar Medical Technologies, Inc. | Apparatus and method for skin treatment with compression and decompression |
US7662177B2 (en) * | 2006-04-12 | 2010-02-16 | Bacoustics, Llc | Apparatus and methods for pain relief using ultrasound waves in combination with cryogenic energy |
JP4265696B2 (en) * | 2006-07-04 | 2009-05-20 | 凸版印刷株式会社 | Manufacturing method of microneedle |
EP2047882B1 (en) * | 2006-07-27 | 2014-09-10 | Toppan Printing Co., Ltd. | Microneedle and method for producing microneedle |
US7586957B2 (en) | 2006-08-02 | 2009-09-08 | Cynosure, Inc | Picosecond laser apparatus and methods for its operation and use |
US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
AU2008209537B2 (en) * | 2007-01-22 | 2013-01-31 | Corium Pharma Solutions, Inc. | Applicators for microneedle arrays |
US9101377B2 (en) * | 2007-01-25 | 2015-08-11 | Biolase, Inc. | Electromagnetic energy output system |
US7815630B2 (en) * | 2007-01-25 | 2010-10-19 | Biolase Technology, Inc. | Target-close electromagnetic energy emitting device |
US7695469B2 (en) * | 2007-01-25 | 2010-04-13 | Biolase Technology, Inc. | Electromagnetic energy output system |
US20080186591A1 (en) * | 2007-02-01 | 2008-08-07 | Palomar Medical Technologies, Inc. | Dermatological device having a zoom lens system |
ES2817249T3 (en) | 2007-04-16 | 2021-04-06 | Corium Inc | Microneedle matrices obtained by dissolution and casting containing an active principle |
US20090225060A1 (en) * | 2007-05-03 | 2009-09-10 | Rizoiu Ioana M | Wrist-mounted laser with animated, page-based graphical user-interface |
US8143034B2 (en) * | 2007-08-21 | 2012-03-27 | Polytechnic Institute Of New York University | Method for preparing long-chain hydroxyacids, diacids and oligomers and polymers thereof |
WO2009048607A1 (en) | 2007-10-10 | 2009-04-16 | Corium International, Inc. | Vaccine delivery via microneedle arrays |
JP5178132B2 (en) * | 2007-10-11 | 2013-04-10 | キヤノン株式会社 | Image processing system and image processing method |
WO2009145920A1 (en) | 2008-05-30 | 2009-12-03 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
ES2907152T3 (en) | 2008-06-06 | 2022-04-22 | Intuity Medical Inc | Blood glucose meter and method of operation |
JP5642066B2 (en) | 2008-06-06 | 2014-12-17 | インテュイティ メディカル インコーポレイテッド | Method and apparatus for performing an assay to determine the presence or concentration of an analyte contained in a sample of body fluid |
KR101013581B1 (en) * | 2008-08-06 | 2011-02-14 | 라종주 | Electric Skin Treatment Device |
US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
TW201027393A (en) | 2009-01-06 | 2010-07-16 | Pixart Imaging Inc | Electronic apparatus with virtual data input device |
ES2634667T3 (en) * | 2009-04-24 | 2017-09-28 | Corium International, Inc. | Methods for manufacturing microprojection assemblies |
US9919168B2 (en) | 2009-07-23 | 2018-03-20 | Palomar Medical Technologies, Inc. | Method for improvement of cellulite appearance |
US9017310B2 (en) * | 2009-10-08 | 2015-04-28 | Palo Alto Research Center Incorporated | Transmucosal drug delivery device and method including microneedles |
US9014799B2 (en) * | 2009-10-08 | 2015-04-21 | Palo Alto Research Center Incorporated | Transmucosal drug delivery device and method including electrically-actuated permeation enhancement |
US8882748B2 (en) | 2009-10-08 | 2014-11-11 | Palo Alto Research Center Incorporated | Transmucosal drug delivery device and method including chemical permeation enhancers |
EP2506768B1 (en) | 2009-11-30 | 2016-07-06 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
ES2719595T3 (en) | 2010-05-04 | 2019-07-11 | Corium Int Inc | Method and device for transdermal administration of parathyroid hormone using a microprojection matrix |
EP2584964B1 (en) | 2010-06-25 | 2021-08-04 | Intuity Medical, Inc. | Analyte monitoring devices |
EP4339613A2 (en) | 2011-08-03 | 2024-03-20 | Intuity Medical, Inc. | Body fluid sampling arrangement |
EP2830499B8 (en) | 2012-03-30 | 2019-04-03 | Insulet Corporation | Fluid delivery device with transcutaneous access tool, insertion mechansim and blood glucose monitoring for use therewith |
US9780518B2 (en) | 2012-04-18 | 2017-10-03 | Cynosure, Inc. | Picosecond laser apparatus and methods for treating target tissues with same |
KR101372403B1 (en) * | 2012-06-21 | 2014-03-25 | 주식회사 파나시 | Pressure Sensitive Automatic Injection System |
US9999720B2 (en) | 2012-09-27 | 2018-06-19 | Palo Alto Research Center Incorporated | Drug reconstitution and delivery device and methods |
US9005108B2 (en) | 2012-09-27 | 2015-04-14 | Palo Alto Research Center Incorporated | Multiple reservoir drug delivery device and methods |
WO2014073531A1 (en) | 2012-11-09 | 2014-05-15 | 凸版印刷株式会社 | Needle-like structure and method for manufacturing same |
CA2896188C (en) | 2012-12-21 | 2021-02-23 | Corium International, Inc. | Microarray for delivery of therapeutic agent and methods of use |
US9744341B2 (en) | 2013-01-15 | 2017-08-29 | Palo Alto Research Center Incorporated | Devices and methods for intraluminal retention and drug delivery |
AU2014249471B2 (en) | 2013-03-12 | 2019-01-24 | Corium Pharma Solutions, Inc. | Microprojection applicators |
EP2973894A2 (en) | 2013-03-15 | 2016-01-20 | Cynosure, Inc. | Picosecond optical radiation systems and methods of use |
JP2016512754A (en) | 2013-03-15 | 2016-05-09 | コリウム インターナショナル, インコーポレイテッド | Microarray, method of use and manufacturing for delivery of therapeutic agents |
CA2903763C (en) | 2013-03-15 | 2021-11-16 | Corium International, Inc. | Microarray with polymer-free microstructures, methods of making, and methods of use |
MX2015012933A (en) | 2013-03-15 | 2016-09-19 | Corium Int Inc | Microarray for delivery of therapeutic agent and methods of use. |
ES2939317T3 (en) | 2013-03-15 | 2023-04-20 | Corium Pharma Solutions Inc | Multi-impact micro-spray applicators |
US20140350518A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Syringe extrusion accessory |
US20140350516A1 (en) | 2013-05-23 | 2014-11-27 | Allergan, Inc. | Mechanical syringe accessory |
JP2016522070A (en) | 2013-06-21 | 2016-07-28 | インテュイティ メディカル インコーポレイテッド | Analyte monitoring system using audible feedback |
US20150038897A1 (en) | 2013-07-30 | 2015-02-05 | Zosano Pharma, Inc. | Low-Profile Microneedle Patch Applicator |
US9297083B2 (en) | 2013-12-16 | 2016-03-29 | Palo Alto Research Center Incorporated | Electrolytic gas generating devices, actuators, and methods |
GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
US10029048B2 (en) | 2014-05-13 | 2018-07-24 | Allergan, Inc. | High force injection devices |
JP6565906B2 (en) | 2014-05-20 | 2019-08-28 | 凸版印刷株式会社 | Needle-like body manufacturing method and needle-like body |
US10278675B2 (en) | 2014-07-31 | 2019-05-07 | Palo Alto Research Center Incorporated | Implantable estrus detection devices, systems, and methods |
US9801660B2 (en) | 2014-07-31 | 2017-10-31 | Palo Alto Research Center Incorporated | Implantable fluid delivery devices, systems, and methods |
US10624843B2 (en) | 2014-09-04 | 2020-04-21 | Corium, Inc. | Microstructure array, methods of making, and methods of use |
US10226585B2 (en) | 2014-10-01 | 2019-03-12 | Allergan, Inc. | Devices for injection and dosing |
EP3258991B1 (en) | 2015-02-18 | 2020-10-21 | Insulet Corporation | Fluid delivery and infusion devices, and methods of use thereof |
EP3268063A4 (en) | 2015-03-10 | 2018-10-31 | Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company | Multiple needle injector |
WO2017004067A1 (en) | 2015-06-29 | 2017-01-05 | Corium International, Inc. | Microarray for delivery of therapeutic agent, methods of use, and methods of making |
US10716896B2 (en) | 2015-11-24 | 2020-07-21 | Insulet Corporation | Wearable automated medication delivery system |
US10413665B2 (en) | 2015-11-25 | 2019-09-17 | Insulet Corporation | Wearable medication delivery device |
US10275573B2 (en) | 2016-01-13 | 2019-04-30 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
US10780223B2 (en) | 2016-01-14 | 2020-09-22 | Bigfoot Biomedical, Inc. | Adjusting insulin delivery rates |
WO2017136268A1 (en) | 2016-02-04 | 2017-08-10 | Insulet Corporation | Anti-inflammatory cannula |
EP3439716B1 (en) | 2016-04-08 | 2023-11-01 | Allergan, Inc. | Aspiration and injection device |
EP3515535A1 (en) | 2016-09-23 | 2019-07-31 | Insulet Corporation | Fluid delivery device with sensor |
US11045603B2 (en) | 2017-02-22 | 2021-06-29 | Insulet Corporation | Needle insertion mechanisms for drug containers |
USD867582S1 (en) | 2017-03-24 | 2019-11-19 | Allergan, Inc. | Syringe device |
US10898656B2 (en) | 2017-09-26 | 2021-01-26 | Insulet Corporation | Needle mechanism module for drug delivery device |
US11147931B2 (en) | 2017-11-17 | 2021-10-19 | Insulet Corporation | Drug delivery device with air and backflow elimination |
KR102627248B1 (en) | 2018-02-26 | 2024-01-19 | 싸이노슈어, 엘엘씨 | Q-switched cavity dumping subnanosecond laser |
WO2019213493A1 (en) | 2018-05-04 | 2019-11-07 | Insulet Corporation | Safety constraints for a control algorithm-based drug delivery system |
CN112789070A (en) | 2018-09-28 | 2021-05-11 | 英赛罗公司 | Mode of activity of the artificial pancreas System |
EP3864668A1 (en) | 2018-10-11 | 2021-08-18 | Insulet Corporation | Event detection for drug delivery system |
US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
US11738144B2 (en) | 2021-09-27 | 2023-08-29 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3964482A (en) * | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
US4340048A (en) * | 1981-03-28 | 1982-07-20 | Alza Corporation | Self-driven hypodermic injector |
US4522622A (en) * | 1982-12-23 | 1985-06-11 | Alza Corporation | Multiple fluid pulse dispenser |
US4775361A (en) * | 1986-04-10 | 1988-10-04 | The General Hospital Corporation | Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport |
GB2221394B (en) | 1988-08-05 | 1992-03-04 | Eilert Eilertsen | An injection device |
US5169389A (en) * | 1989-06-16 | 1992-12-08 | Science, Inc. | Fluid delivery apparatus |
EP0429842B1 (en) * | 1989-10-27 | 1996-08-28 | Korea Research Institute Of Chemical Technology | Device for the transdermal administration of protein or peptide drug |
US5115805A (en) | 1990-02-23 | 1992-05-26 | Cygnus Therapeutic Systems | Ultrasound-enhanced delivery of materials into and through the skin |
US5137817A (en) * | 1990-10-05 | 1992-08-11 | Amoco Corporation | Apparatus and method for electroporation |
US5279544A (en) | 1990-12-13 | 1994-01-18 | Sil Medics Ltd. | Transdermal or interdermal drug delivery devices |
US5312456A (en) | 1991-01-31 | 1994-05-17 | Carnegie Mellon University | Micromechanical barb and method for making the same |
US5223219A (en) | 1992-04-10 | 1993-06-29 | Biotrack, Inc. | Analytical cartridge and system for detecting analytes in liquid samples |
US5421816A (en) | 1992-10-14 | 1995-06-06 | Endodermic Medical Technologies Company | Ultrasonic transdermal drug delivery system |
US5582184A (en) * | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
US5458140A (en) * | 1993-11-15 | 1995-10-17 | Non-Invasive Monitoring Company (Nimco) | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
US5445611A (en) * | 1993-12-08 | 1995-08-29 | Non-Invasive Monitoring Company (Nimco) | Enhancement of transdermal delivery with ultrasound and chemical enhancers |
DE59505328D1 (en) | 1994-12-09 | 1999-04-15 | Novartis Ag | TRANSDERMAL SYSTEM |
TR199800347T1 (en) * | 1995-08-29 | 1998-05-21 | Spectrx, Inc. | Micro-poring of human skin for drug application and monitoring applications. |
US5801057A (en) | 1996-03-22 | 1998-09-01 | Smart; Wilson H. | Microsampling device and method of construction |
JP2828064B2 (en) * | 1996-09-20 | 1998-11-25 | 日本電気株式会社 | Suction leachate collection method and device |
US6071249A (en) | 1996-12-06 | 2000-06-06 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
JP2001512329A (en) * | 1996-12-31 | 2001-08-21 | アルテア テクノロジーズ,インコーポレイテッド | Tissue microperforation for bioactive drug delivery |
US6155992A (en) | 1997-12-02 | 2000-12-05 | Abbott Laboratories | Method and apparatus for obtaining interstitial fluid for diagnostic tests |
WO1999040848A1 (en) | 1998-02-17 | 1999-08-19 | Abbott Laboratories | Interstitial fluid collection and monitoring device |
US6022316A (en) * | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
-
1997
- 1997-07-03 US US09/202,207 patent/US6183434B1/en not_active Expired - Lifetime
- 1997-07-03 CA CA002259437A patent/CA2259437C/en not_active Expired - Lifetime
- 1997-07-03 WO PCT/US1997/011670 patent/WO1998000193A1/en active IP Right Grant
- 1997-07-03 AT AT97936041T patent/ATE241405T1/en not_active IP Right Cessation
- 1997-07-03 DK DK97936041T patent/DK0921840T3/en active
- 1997-07-03 ES ES97936041T patent/ES2200187T3/en not_active Expired - Lifetime
- 1997-07-03 JP JP50448898A patent/JP3942640B2/en not_active Expired - Fee Related
- 1997-07-03 EP EP97936041A patent/EP0921840B1/en not_active Expired - Lifetime
- 1997-07-03 DE DE69722414T patent/DE69722414T2/en not_active Expired - Lifetime
- 1997-07-03 AU AU38806/97A patent/AU3880697A/en not_active Abandoned
-
2001
- 2001-05-10 US US09/852,935 patent/US20020010412A1/en not_active Abandoned
Cited By (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050119605A1 (en) * | 2002-04-19 | 2005-06-02 | Transpharma Medical Ltd. | Handheld transdermal drug delivery and analyte extraction |
US8337493B2 (en) | 2002-04-19 | 2012-12-25 | Syneron Medical Ltd | Handheld transdermal drug delivery and analyte extraction |
US20110178518A1 (en) * | 2002-04-19 | 2011-07-21 | Transpharma Medical, Ltd. | Handheld transdermal drug delivery and analyte extraction |
US20090270792A1 (en) * | 2002-08-29 | 2009-10-29 | Lastovich Alexander G | Microprotrusion arrays and methods for using same to deliver substances into tissue |
US20040077994A1 (en) * | 2002-08-29 | 2004-04-22 | Lastovich Alexander G. | Microprotrusion arrays and methods for using same to deliver substances into tissue |
US7166086B2 (en) | 2002-08-29 | 2007-01-23 | Becton, Dickinson And Company | Substance delivery via a rotating microabrading surface |
US7316671B2 (en) | 2002-08-29 | 2008-01-08 | Becton, Dickinson And Company | Microprotrusion arrays and methods for using same to deliver substances into tissue |
US7422567B2 (en) | 2002-08-29 | 2008-09-09 | Becton, Dickinson And Company | Microabrader with controlled abrasion features |
US8075826B2 (en) | 2002-08-29 | 2011-12-13 | Becton, Dickinson And Company | Microprotrusion arrays and methods for using same to deliver substances into tissue |
US20040064087A1 (en) * | 2002-08-29 | 2004-04-01 | Lastovich Alexander G. | Microabrader with controlled abrasion features |
US20090118672A1 (en) * | 2002-10-07 | 2009-05-07 | Gonnelli Robert R | Microneedle array patch |
US8162901B2 (en) | 2002-10-07 | 2012-04-24 | Valeritas, Inc. | Microneedle array patch |
US20080274166A1 (en) * | 2005-06-10 | 2008-11-06 | Transpharma Medical Ltd. | Patch for Transdermal Drug Delivery |
US20080234626A1 (en) * | 2006-04-26 | 2008-09-25 | Chelak Todd M | Multi-stage microporation device |
US10208158B2 (en) | 2006-07-10 | 2019-02-19 | Medipacs, Inc. | Super elastic epoxy hydrogel |
US20090053673A1 (en) * | 2007-08-23 | 2009-02-26 | Zimmer, Inc. | Method for localized treatment of periodontal tissue |
US20100286588A1 (en) * | 2007-10-09 | 2010-11-11 | Transpharma Ltd. | Magnetic patch coupling |
US9037229B2 (en) | 2007-10-09 | 2015-05-19 | Syneron Medical Ltd | Magnetic patch coupling |
US8281675B2 (en) | 2007-10-17 | 2012-10-09 | Syneron Medical Ltd | Dissolution rate verification |
US20100229636A1 (en) * | 2007-10-17 | 2010-09-16 | Galit Levin | Dissolution rate verification |
US20100293807A1 (en) * | 2007-10-29 | 2010-11-25 | Transpharma Medical, Ltd. | Vertical patch drying |
US9995295B2 (en) | 2007-12-03 | 2018-06-12 | Medipacs, Inc. | Fluid metering device |
US9011419B2 (en) | 2007-12-05 | 2015-04-21 | Syneron Medical Ltd | Disposable electromagnetic energy applicator |
US9022973B2 (en) | 2007-12-17 | 2015-05-05 | New World Pharmaceuticals, Llc | Integrated intra-dermal delivery, diagnostic and communication system |
US10384005B2 (en) | 2007-12-17 | 2019-08-20 | New World Pharmaceuticals, Llc | Integrated intra-dermal delivery, diagnostic and communication system |
US20090187167A1 (en) * | 2007-12-17 | 2009-07-23 | New World Pharmaceuticals, Llc | Integrated intra-dermal delivery, diagnostic and communication system |
EP2280645A2 (en) * | 2008-05-02 | 2011-02-09 | Aspect Medical Systems, Inc. | Skin preparation device and biopotential sensor |
EP2280645A4 (en) * | 2008-05-02 | 2013-09-18 | Aspect Medical Systems Inc | Skin preparation device and biopotential sensor |
US20110172486A1 (en) * | 2008-06-27 | 2011-07-14 | Quentin Andrew Pankhurst | Magnetic microbubbles, methods of preparing them and their uses |
US9427396B2 (en) | 2008-06-27 | 2016-08-30 | Ucl Business Plc | Magnetic microbubbles, methods of preparing them and their uses |
US9504826B2 (en) | 2009-02-18 | 2016-11-29 | Syneron Medical Ltd | Skin treatment apparatus for personal use and method for using same |
US9238102B2 (en) | 2009-09-10 | 2016-01-19 | Medipacs, Inc. | Low profile actuator and improved method of caregiver controlled administration of therapeutics |
US20110172639A1 (en) * | 2010-01-08 | 2011-07-14 | Ratio, Inc. | Device and method for delivery of microneedle to desired depth within the skin |
US20110172645A1 (en) * | 2010-01-08 | 2011-07-14 | Ratio, Inc. | Wearable drug delivery device including integrated pumping and activation elements |
US20110172637A1 (en) * | 2010-01-08 | 2011-07-14 | Ratio, Inc. | Drug delivery device including tissue support structure |
US20110172609A1 (en) * | 2010-01-08 | 2011-07-14 | Ratio, Inc. | Microneedle component assembly for drug delivery device |
US9500186B2 (en) | 2010-02-01 | 2016-11-22 | Medipacs, Inc. | High surface area polymer actuator with gas mitigating components |
CN102905755A (en) * | 2010-03-01 | 2013-01-30 | 因诺维奥制药公司 | A tolerable and minimally invasive skin electroporation device |
WO2011109406A1 (en) * | 2010-03-01 | 2011-09-09 | Inovio Pharmaceuticals, Inc. | A tolerable and minimally invasive skin electroporation device |
AU2011223753B2 (en) * | 2010-03-01 | 2014-06-26 | Inovio Pharmaceuticals, Inc. | A tolerable and minimally invasive skin electroporation device |
US11565107B2 (en) * | 2010-03-01 | 2023-01-31 | Inovio Pharmaceuticals, Inc. | Tolerable and minimally invasive skin electroporation device |
EA025705B1 (en) * | 2010-03-01 | 2017-01-30 | Иновио Фармасьютикалз, Инк. | Tolerable and minimally invasive skin electroporation device |
US20130066296A1 (en) * | 2010-03-01 | 2013-03-14 | Kate Broderick | Tolerable and minimally invasive skin electroporation device |
US8668675B2 (en) | 2010-11-03 | 2014-03-11 | Flugen, Inc. | Wearable drug delivery device having spring drive and sliding actuation mechanism |
CN103687644A (en) * | 2011-06-28 | 2014-03-26 | 艾诺奥医药品有限公司 | A miniminally invasive dermal electroporation device |
US10000605B2 (en) | 2012-03-14 | 2018-06-19 | Medipacs, Inc. | Smart polymer materials with excess reactive molecules |
CN104508675A (en) * | 2012-05-30 | 2015-04-08 | 斯科特·麦克纳尔蒂 | System, method and apparatus for electromagnetic detection and analysis of biometric information |
US20170232246A1 (en) * | 2014-11-07 | 2017-08-17 | Toppan Printing Co., Ltd. | Needle assembly for transdermal administration and method of producing the same |
US10799691B2 (en) * | 2014-11-07 | 2020-10-13 | Toppan Printing Co., Ltd. | Needle assembly for transdermal administration and method of producing the same |
WO2018080923A1 (en) * | 2016-10-28 | 2018-05-03 | Georgetown University | Non-invasive passive interstitial fluid collector |
US11534090B2 (en) | 2016-10-28 | 2022-12-27 | Georgetown University | Non-invasive passive interstitial fluid collector |
US11247206B2 (en) | 2017-01-31 | 2022-02-15 | Georgetown University | Harvesting cell-free non-coding RNAS (CFNCRS) from interstitial fluid for sensitive biomarkers |
Also Published As
Publication number | Publication date |
---|---|
WO1998000193A1 (en) | 1998-01-08 |
DE69722414T2 (en) | 2004-05-19 |
US6183434B1 (en) | 2001-02-06 |
CA2259437A1 (en) | 1998-01-08 |
EP0921840A1 (en) | 1999-06-16 |
EP0921840A4 (en) | 2000-04-12 |
CA2259437C (en) | 2006-12-05 |
DE69722414D1 (en) | 2003-07-03 |
ES2200187T3 (en) | 2004-03-01 |
JP3942640B2 (en) | 2007-07-11 |
ATE241405T1 (en) | 2003-06-15 |
AU3880697A (en) | 1998-01-21 |
JP2000513971A (en) | 2000-10-24 |
EP0921840B1 (en) | 2003-05-28 |
DK0921840T3 (en) | 2003-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6183434B1 (en) | Multiple mechanical microporation of skin or mucosa | |
US8172815B2 (en) | Device for withdrawing or administrating a substance and method of a device | |
Gardeniers et al. | Silicon micromachined hollow microneedles for transdermal liquid transport | |
JP4668535B2 (en) | A device that supplies or withdraws substances through the skin of animals | |
DE69937338T2 (en) | INTEGRATED TISSUE PORATION, LIQUID COLLECTION AND ANALYSIS DEVICE | |
EP1652551B1 (en) | Microneedle arrays | |
AU2007202052B2 (en) | Microneedle devices and production thereof | |
US7344499B1 (en) | Microneedle device for extraction and sensing of bodily fluids | |
JP4892166B2 (en) | Micro device and method for manufacturing the same | |
US5879326A (en) | Method and apparatus for disruption of the epidermis | |
US9717451B2 (en) | Device for withdrawing or administering a substance and method of manufacturing a device | |
JP2007325955A (en) | System for delivery of drug by transport | |
US20080058726A1 (en) | Methods and Apparatus Incorporating a Surface Penetration Device | |
JP2003534881A (en) | Method and apparatus for enhancing penetration of a piercing member into an intradermal space | |
JP2004505652A (en) | Apparatus for microporation of biological membranes using thin-film tissue interface devices and methods therefor | |
Zahn | Microfabricated microneedles for minimally invasive drug delivery, sampling and analysis | |
Zhang et al. | Micromachined needles for microbiological sample and drug delivery system | |
Tan et al. | Novel low-cost fabrication of microneedle arrays for drug delivery applications | |
Griss | Micromachined interfaces for medical and biochemical applications | |
AU2002253812A1 (en) | Microneedle devices and production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: ALTEA THERAPEUTICS CORPORATION, GEORGIA Free format text: CHANGE OF NAME;ASSIGNOR:ALTEA DEVELOPMENT CORP.;REEL/FRAME:013295/0519 Effective date: 20021120 Owner name: ALTEA DEVELOPMENT CORP., GEORGIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ALTEA TECHNOLOGIES, INC.;REEL/FRAME:013295/0426 Effective date: 20021107 |
|
AS | Assignment |
Owner name: ALTEA DEVELOPMENT CORP., GEORGIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ALTEA TECHNOLOGIES, INC.;REEL/FRAME:013699/0145 Effective date: 20021107 |
|
AS | Assignment |
Owner name: ALTEA THERAPEUTICS CORPORATION, GEORGIA Free format text: CHANGE OF NAME;ASSIGNOR:ALTEA DEVELOPMENT CORP.;REEL/FRAME:013699/0641 Effective date: 20021108 |
|
AS | Assignment |
Owner name: ALTEA DEVELOPMENT CORP., GEORGIA Free format text: CHANGE OF NAME;ASSIGNOR:ALTEA TECHNOLOGIES, INC.;REEL/FRAME:013746/0511 Effective date: 20030108 |